Professional Documents
Culture Documents
Index
Up/Down
Last
DJ Industrials
69.35
0.40%
17,477
S&P 500
8.24
0.40%
2,091
Nasdaq
14.68
0.29%
5,048
Russell 2000
7.92
0.65%
1,212
Economic Data
U.S. producer prices moderated in July rose a seasonally adjusted 0.2% after a 0.4% gain in the
prior month (and slightly above estimate for a 0.1% increase). PPI core (ex: food & energy) rose
0.3%, above estimates for a 0.1% and after a 0.3% gain in June. The prices of goods fell 0.1%
while services rose 0.4%, the biggest gain since last October.
Industrial Production for July rose 0.6%, above est. 0.3%, but June was downwardly revised to a
0.1% rise form 0.3% prior; Capacity utilization rose to 78% from 77.7% in June (and was in-line
with consensus forecasts); Factory production rose 0.8% in July after falling 0.3% in June
Prelim August Michigan Sentiment declined to 92.9 vs. 93.5 est. (survey for Aug. fell to 92.9 vs.
93.1 prior month: said the current economic conditions index fell to 107.1 vs. 107.2 last month
and expectations index fell to 83.8 vs. 84.1 last month.
Commodities
Crude oil prices ended slightly higher on Friday, but down for the week. WTI crude rose 27c, or
0.64% to settle at $42.50 per barrel, but it wasnt enough, as the contract posted its 7th straight
weekly decline, falling 3.1%. Brent prices slipped slightly on the day, also posting another losing
week. Also midday, The U.S. Commerce Department informed members of Congress that it
intends to approve an application by Mexicos national oil company, Petrleos Mexicanos SA, to
enter into oil trade agreements with U.S. companies under which the companies could exchange
U.S. and Mexican oil (refiners moved lower on headlines).
Gold prices ended lower by $2.90, or 0.3% to settle at $1,112.70 an ounce, but still registered a
weekly gain of about 1.6%, its biggest in about two months. Gold prices were higher initially after
a higher inflation reading, and on reports China increased its gold reserves to 53.93 million troy
ounces by the end of July from 53.32 million ounces a month earlier, according to the central
bank, but gold succumbed to profit taking late day.
Macro
Up/Down
Last
WTI Crude
0.27
42.50
Brent
-0.19
49.03
Gold
-2.90
1,112.70
EUR/USD
-0.0031
1.1118
JPY/USD
-0.17
124.26
10-Year Note
0.005
2.194%
Financials
Financials as a group performed better today, adding on to gains Thursday, as rates edge higher;
group remains focused on timing of potential FOMC rate hike lift-off (China fears eased from
earlier in the week, economic data pointed positive today bonds fell and rate expectations
increased); insurance, banking, regionals all moved higher
Online brokers with monthly metrics: 1) ETFC said July DARTs were up 6.6% MoM to 149,283, but
down 2.9% YoY from 153,671; says added 29,623 gross new brokerage accounts, ended the
month with 3.19M vs. 3.2M MoM; 2) SCHW July net new assets $9.8B and total client assets
$2.56 trillion at July end, up 8% YoY
Healthcare
Large Cap Pharma; PRGO advanced after the WSJ reported Hedge Fund Paulson is buying PRGO
shares (which also owns 4.6% of MYL, which is bidding $36B for PRGO) http://goo.gl/btzoxF ;
other 13-F filings today showed Kyle Bass took stake in PRGO as well (in addition to new positions
in PFE, LLY, MRK and MYL according to CNBC); PFE received approval for its HSP purchase (had to
sell 4 products to resolve competition concerns)/Piper also positive on PFE saying estimates too
low; managed care stocks were active midday (AET, HUM moved); ENDP advanced as it won
ruling that Actavis (bought by AGN in March) infringed two Opana patents and has 60-days to
remove the generic painkiller
Biotech; biotech sell-off, as ETF IBB falls early back below 100 day (364.70) earlier today on
CNBC interview, LLY CEO said many biotechs are too expensive to buy; ALXN falls after 6.48M
share offering last night; weakness in smaller cap names, like CAR-T JUNO, KITE, BLUE; ICPT adds
to 7.8% decline Thursday after Morgan initiated Underweight and $165 tgt
Other movers; AAVL dropped after saying it wont initiate Phase 2b trial in 2H of 2015 after
further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet
age-related macular degeneration (tgt cut to $20 from $51 at Jefferies); KMPH reports positive
data on KP201/APAP and sees NDA in Q4 (Cowen street high $55 tgt); KITE declined as Cowen
noted drop could be linked to unsubstantiated possibility of a patient death in lead-in portion of
Phase 1/2 trial in diffuse large B-Cell lymphoma; WX rises after earnings; CPHD CFO leaves
Industrials & Materials
AG & Machinery; NAV upgraded to Market Perform at BMO Capital as believe the risk/reward
profile has come much more in balance; ETN was cut to neutral at Argus; DAR Q2 EPS beats and
announces buyback; GE is expected to win EU antitrust approval for its proposed EUR12.4B
acquisition of Alstom's power unit, Reuters reports http://goo.gl/vaE7vN
Metals & Mining; Miner EGO upgraded at BMO Capital on several positive upcoming catalysts;
regarding iron ore, BHP said normal iron ore shipments have been restored at the Chinese port of
Tianjin after deadly blasts caused disruptions, while RIO said four fully laden bulk carriers were
re-routed (note iron ore on the Dalian Commodity Exchange jumped 2.7% yesterday to the
highest in more than a month on news of the disruptions, but prices slipped today)
Chemicals; DD upgraded to Overweight at JP Morgan noting share underperformance vs. the S&P
500 says benefited over a five-year period from sharply positive cyclical fundamentals in
agriculture, titanium dioxide, solar, and North American petrochemicals; in ag chemical, CF was
upgraded to Overweight at Barclays citing recently announced deals to stay ahead
Want a free trial to The Hammerstone Report 4x Daily ? Sign-up for a trial today at
www.thehammerstonereport.com
Please be sure to check out The Hammerstone Institutional Feed for News and Analysis for the
Informed Trader at www.hammerstoneinstitutional.com
***DISCLAIMER/LIMITATION OF LIABILITY: Hammerstone Inc. (the Report) provides information and data and does NOT provide any individual investment advice or money management
assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment
decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The
Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer t o buy or sell any securities. The Report is prepared for
general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity